Literature DB >> 22021455

Is there still a place for myeloablative regimen to transplant young adults with sickle cell disease?

Mathieu Kuentz, Marie Robin, Nathalie Dhedin, Yosr Hicheri, Regis Peffault de Latour, Pierre Rohrlich, Pierre Bordigoni, Bénédicte Bruno, Gérard Socié, Françoise Bernaudin.   

Abstract

Mesh：

Year:  2011        PMID： 22021455     DOI： 10.1182/blood-2011-07-367490

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

Review 1.  Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.

Authors:  Gregory M T Guilcher; Tony H Truong; Santosh L Saraf; Jacinth J Joseph; Damiano Rondelli; Matthew M Hsieh
Journal:  Semin Hematol       Date:  2018-04-25       Impact factor: 3.851

Review 2.  Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease.

Authors:  Hitomi Hosoya; Jeffrey Levine; Peter Abt; David Henry; David L Porter; Saar Gill
Journal:  Blood Adv       Date:  2018-03-13

3.  Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.

Authors:  Emanuele Angelucci; Susanne Matthes-Martin; Donatella Baronciani; Françoise Bernaudin; Sonia Bonanomi; Maria Domenica Cappellini; Jean-Hugues Dalle; Paolo Di Bartolomeo; Cristina Díaz de Heredia; Roswitha Dickerhoff; Claudio Giardini; Eliane Gluckman; Ayad Achmed Hussein; Naynesh Kamani; Milen Minkov; Franco Locatelli; Vanderson Rocha; Petr Sedlacek; Frans Smiers; Isabelle Thuret; Isaac Yaniv; Marina Cavazzana; Christina Peters
Journal:  Haematologica       Date:  2014-05       Impact factor: 9.941

Review 4.  Update of hematopoietic cell transplantation for sickle cell disease.

Authors:  Mark C Walters
Journal:  Curr Opin Hematol       Date:  2015-05       Impact factor: 3.284

Review 5.  Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.

Authors:  Mark C Walters; Laura M De Castro; Keith M Sullivan; Lakshmanan Krishnamurti; Naynesh Kamani; Christopher Bredeson; Donna Neuberg; Kathryn L Hassell; Stephanie Farnia; Andrew Campbell; Effie Petersdorf
Journal:  Biol Blood Marrow Transplant       Date:  2015-10-21       Impact factor: 5.742

6.  Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France.

Authors:  Françoise Bernaudin; Jean-Hugues Dalle; Dominique Bories; Regis Peffault de Latour; Marie Robin; Yves Bertrand; Corinne Pondarre; Jean-Pierre Vannier; Benedicte Neven; Mathieu Kuentz; Sébastien Maury; Patrick Lutz; Catherine Paillard; Karima Yakouben; Isabelle Thuret; Claire Galambrun; Nathalie Dhedin; Charlotte Jubert; Pierre Rohrlich; Jacques-Olivier Bay; Felipe Suarez; Nicole Raus; Jean-Paul Vernant; Eliane Gluckman; Catherine Poirot; Gérard Socié
Journal:  Haematologica       Date:  2019-05-16       Impact factor: 9.941

Review 7.  Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease.

Authors:  Santosh L Saraf; Damiano Rondelli
Journal:  J Clin Med       Date:  2019-10-01       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.